hsa-miR-339-5p

ncRNA information

ncRNA name

hsa-miR-339-5p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Upstream regulatory factors

Not available

Downstream target

FUT1

Cancer information

Cancer name

Small Cell Lung Cancer

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Paclitaxel

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-339-5p Downregulation Contributes to Taxol Resistance in Small-Cell Lung Cancer.

Tissue resource

human non-small cell lung cancer taxol-resistant cell lines Taxol-A549

human non-small cell lung cancer cell lines A549

human non-small cell lung cancer cell lines H1299

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Nanjing KeyGen Biotech Co., Ltd.

Country

China

Continent

Asia